Clinically relevant drug–drug interactions in oncology
- 作者Howard L. McLeod
- 卷第45卷
- 期第6期
- 印刷ISSN0306-5251
- 电子ISSN1365-2125
- 文件大小90.29KB
- 发表时间1998
- DOI10.1046/j.1365-2125.1998.00719.x
- 页码539-544
Pharmacokinetics of recombinant human interleukin-3 in rhesus monkeysZhongming Tang; Xiuwen Liu; Min Tu · 1997
Pharmacokinetics of [125I]-recombinant human interleukin-11:T. Uchida; K. Aoyama; K. Mori; T. Usui; T. Watanabe; Y. Takariki; N. Asahara; M. Hirose; T. Kimura; M. Tateishi; S. Higuchi · 1998
Pharmacokinetics and Leukocyte Responses of Recombinant Human Interleukin-10Elaine Radwanski; Abhijit Chakraborty; Scott Van Wart; Richard D. Huhn; David L. Cutler; Melton B. Affrime; William J. Jusko · 1998
Pharmacokinetics and Pharmacodynamics of Subcutaneous Injection and Intravenous Infusion of Recombinant Human Interleukin-12 and Recombinant Human Interleukin-12 Combined with Hepatitis B Surface Antigen in Cynomolgus MonkeysLi, Rubing; Deng, Fengjun; Fu, Yonghang; Zhang, Yijun; Wan, Huayin; Zhou, Dan; Gu, Jingliang; Xu, Jiangping · Pharmacology · 2010
Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in miceHoward Sands; Scott E. Loveless · 1989
Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjectsK. Aoyama; T. Uchida; F. Takanuki; T. Usui; T. Watanabe; S. Higuchi; T. Toyoki; H. Mizoguchi · 1997
The pharmacokinetics and distribution of authentic human recombinant interleukin 1β (rhIL-1β) in normal rats1991
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansGranowitz, Eric V.; Porat, Reuven; Mier, James W.; Pribble, John P.; Stiles, David M.; Bloedow, Duane C.; Catalano, Michael A.; Wolff, Sheldon M.; Dinarello, Charles A. · 1992